. Author manuscript; available in PMC: 2017 Sep 26.

Published in final edited form as: Clin Lymphoma Myeloma Leuk. 2014 Jan 15;14(4):319–326. doi: 10.1016/j.clml.2014.01.002

Table 3.

Survival and Disease Outcomes based Pre-Transplant Characteristics

	(73 Events)		(84 Events)
Characteristic	Hazard Ratio (95% CI)	P-value	Hazard Ratio (95% CI)	P-value
MRD Pre-Transplant (No: Yes)	0.66 (0.37, 1.15)	0.14	0.62 (0.37, 1.04)	0.07
Age (<40:≥40)	0.49 (0.30, 0.82)	0.01	0.50 (0.31, 0.81)	0.004
Disease Status (1^st: Later CR/CRi)	0.60 (0.36, 0.99)	0.05	0.63 (0.397, 1.00)	0.05
Allotype (Related: Unrelated)	0.54 (0.32, 0.92)	0.02	NI
Cell Type (PB: BM)	1.9 (1.03, 3.34)	0.04	NI

NI =Not Included, indicates that the variable was not included in the final model after the selection procedure was finished. Every model was required to include MRD. The remaining variables in the full model were age, sex, disease status, histology, conditioning regimen, allotype, and cell type. Only variables that were significantly associated with at least one outcome after model selection are listed in the table.